TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05614245

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Study was halted prematurely prior to enrollment of first participant based on study sponsor's decision to prioritize clinical development of VBI-2901a.”

The sponsor’s own words in the registry.

Life of this trial

202220232024Registered2022-11-02Planned start2023-03 (planned)Withdrawn (as of)2023-04-04

Vital statistics

Status
Withdrawn
Phase
Phase 1
Sponsor
VBI Vaccines Inc.
Sponsor type
Industry
Conditions
COVID-19; Coronavirus Infections
Interventions
VBI-2901e
Participants
0
Sites
4
Countries
Canada

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.